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Summary
 
T lymphocyte recognition of infected cells is mediated by T cell receptors (TCRs) interacting
with their ligands, self–major histocompatibility complex (MHC) molecules complexed with
pathogen-derived peptides. Serial TCR interactions with potentially small numbers of MHC/
peptide complexes on infected cells transmit signals that result in T lymphocyte expansion and
activation of effector functions. The impact of TCR affinity for MHC/peptide complexes on
the rate or extent of in vivo T cell expansion is not known. Here we show that in vivo expan-
sion of complex T cell populations after bacterial infection is accompanied by an increase in
their overall affinity for antigen. T cell populations that have undergone additional rounds of in
vivo expansion express a narrower range of TCRs, have increased sensitivity for antigen in cy-
totoxic T lymphocyte assays, and bind MHC/peptide complexes with greater affinity. The se-
lective expansion of higher affinity T cells provides an in vivo mechanism for optimizing the
early detection of infected cells.
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R
 
eceptor–ligand interactions are fundamental to bio-
logical systems and the affinity of these interactions
can be an important regulatory parameter. The binding of
antibodies to antigen during immune responses to infec-
tious pathogens represents a receptor–ligand interaction in
which affinities evolve (1, 2). B lymphocytes are activated
and expand in germinal centers of lymph nodes and the
spleen upon antigen challenge (3). Over time, antigen-spe-
cific B cell populations enhance the affinity of the antibod-
ies they produce by somatically mutating their rearranged
immunoglobulin variable (V) genes (4–6). Despite similari-
ties in the strategy for establishing diversity and the general
structure of antibodies and TCRs, it is unknown whether
TCR–MHC/peptide affinity evolves during antigen stim-
ulation. Since TCRs are coupled to signaling pathways that
influence T cell activation, proliferation, and effector func-
tions, evolving TCR affinities could have dramatic effects
on T cell phenotypes during immune responses.
The importance of TCR affinity for MHC/peptide
complexes has been clearly demonstrated at the level of
thymic T cell development (7, 8) and during the activation
of mature T cells (9–12). Changes in the affinity of TCR
interactions with MHC/peptide complexes can enhance or
antagonize T cell activation, or selectively activate different
effector functions. However, the role of TCR affinity on T
cell responses during infection is unclear. The finding that
many antigen-specific T cell responses during infection are
highly diverse (13–17) suggests that the affinities of the re-
sponding T cells for antigen may not be uniform. Several
recent studies have demonstrated evolution of the TCR
repertoire during in vivo T cell expansion (18–20). Al-
though it has been postulated that epitope-specific T cell
populations undergo affinity maturation during in vivo an-
tigen challenge, the complexity of T cell responses has
made it difficult to directly demonstrate this.
We have used murine infection with 
 
Listeria monocy-
togenes
 
 as a model system to study MHC class I–restricted
T cell responses. Infections of mice with a sublethal dose
of 
 
L
 
.
 
 monocytogenes
 
 are rapidly cleared and induce long
lasting immunity, which is mediated, in part, by MHC
class I–restricted CTLs (21, 22). The peptide specificity of
 
L
 
.
 
 monocytogenes
 
–specific CTLs has been determined and
the kinetics of the T cell responses to the different epitopes
was measured using MHC class I tetramers (23–26). The
immunodominant 
 
Listeria
 
 epitope listeriolysin O (LLO)
 
91–99
1
 
elicits T cell populations with a diverse TCR V
 
b
 
 repertoire
after primary infection, which is maintained by the memory
T cell population (20). Reinfection with 
 
L
 
.
 
 monocytogenes
 
 re-
sults in dramatic expansion of memory T cells specific for
LLO
 
91–99
 
 and focusing of the TCR repertoire.
 
1
 
Abbreviations used in this paper:
 
 LLO, listeriolysin O; SA, streptavidin; SB,
staining buffer. 
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In this paper, we demonstrate that in vivo expansion of
LLO
 
91–99
 
–specific T cell populations after 
 
L
 
.
 
 monocytogenes
 
reinfection results in an increase in their affinity for antigen.
We used tetrameric MHC/peptide complexes to directly
identify complex, LLO
 
91–99
 
–specific T cell populations dur-
ing primary and recall infection with 
 
L
 
.
 
 monocytogenes
 
, and
we applied and extended a recently described approach
(27) using MHC tetramers to estimate the relative affinity
of their TCR–MHC/peptide interactions. Using these
novel assays, we show that bacterial infection drives the se-
lective expansion of higher affinity T cells, thereby increas-
ing the overall affinity of complex, antigen-specific T cell
populations. The functional implications of selective T cell
expansion and in vivo T cell affinity maturation for specific
immunity to pathogens are discussed.
 
Materials and Methods
 
Mice, Bacteria, and Cell Lines
 
BALB/c mice were obtained from The Jackson Laboratory. For
primary infection, 2,000 
 
L
 
.
 
 monocytogenes
 
 10403s (obtained from
Daniel Portnoy, University of California, Berkeley, CA) were in-
jected into the tail vein of 8–10-wk-old mice. Reimmunization was
performed by intravenous injection of 100,000 
 
L
 
.
 
 monocytogenes
 
10403s 5 wk after primary infection. The P815 mastocytoma cell
line (H2
 
d
 
) was obtained from the American Type Culture Center.
 
Generation and Purification of H2-K
 
d
 
/LLO
 
91–99
 
 Tetramers
 
Tetrameric H2-K
 
d
 
/LLO
 
91–99
 
 complexes were generated as re-
cently described (26). After multimerization of refolded and bi-
otinylated MHC/peptide complexes with PE-conjugated strepta-
vidin (SA-PE; Molecular Probes), tetrameric H2-K
 
d
 
/LLO
 
91–99
 
/
SA-PE complexes were purified by gel filtration over a Superdex
200 HR column (Pharmacia). This final gel filtration step is nec-
essary for tetramer binding or dissociation studies, in order to
eliminate the substantial proportion of lower multimeric forms
after incubation with SA-PE. Streptavidin conjugates were used
because reagents, such as deglycosylated avidin products, form
larger aggregates. Purified tetramers were stored at 2–5 mg/ml at
4
 
8
 
C in PBS (pH 8.0) containing 0.02% sodium azide, 1 
 
m
 
g/ml
pepstatin, 1 
 
m
 
g/ml leupeptin, and 0.5 mM EDTA. To increase
the reproducibility and comparability of the presented studies, all
experiments were performed using the same batch of H2-K
 
d
 
/
LLO
 
91–99
 
 tetramer reagent. The reagents were frequently tested
on LLO
 
91–99
 
–specific T cell lines to document the maintenance of
staining capacity and signal intensity.
 
Short-Term In Vitro Peptide Stimulation
 
T cell lines were established by in vitro peptide stimulation as
recently described (17, 20). Spleens were removed 7 d after pri-
mary infection or 5 d after reinfection with 
 
L
 
.
 
 monocytogenes
 
, and
splenocytes were harvested by dissociation through a wire mesh
and lysis of erythrocytes with ammonium chloride, and subse-
quently resuspended in RP10
 
1
 
, which consists of RPMI 1640
(GIBCO BRL) supplemented with 10% FCS, 
 
l
 
-glutamine,
Hepes (pH 7.5), 
 
b
 
-ME, penicillin (100 U/ml), streptomycin (100
 
m
 
g/ml), and gentamicin (50 
 
m
 
g/ml). 4 
 
3 
 
10
 
7
 
 responder spleno-
cytes were incubated in the presence of 3 
 
3 
 
10
 
7
 
 irradiated, synge-
neic spleen cells that were peptide-pulsed for 1 h at 37
 
8
 
C with
 
10
 
2
 
9
 
 M LLO
 
91–99
 
 peptide (17). Cell lines were cultured in 10 ml
RP10
 
1
 
 medium supplemented with 5% rat Con A supernatant
and were analyzed after 5 d of incubation. Short-term in vitro
expansion of LLO
 
91–99
 
–specific T cell lines from peripheral blood
was performed as recently described (20).
 
Enrichment for CD8
 
1
 
 T Cells
 
Splenocytes were enriched for CD8
 
1
 
 T cells by depletion, us-
ing magnetically activated cell sorting (MACS; Miltenyi, Ger-
many) with anti-CD4 (GK1.4), anti–MHC class II (TIB120),
anti–MAC-1 (TIB128) mAbs, and anti–rat IgG microbeads
(Miltenyi). The purity of CD8
 
1
 
 T cells was between 70 and 85%,
as determined by flow cytometry.
 
CTL Assays
 
Standard Cr-release assays using 
 
51
 
Cr-labeled P815 target cells
were performed as previously described (17). For peptide titra-
tions using T cell lines, the percentage of specific lysis was deter-
mined in duplicates over a range of different peptide concentra-
tions at a constant E/T ratio of 
 
z
 
10:1. For direct ex vivo CTL
assays, 6 
 
3 
 
10
 
6
 
 CD8
 
1
 
-enriched T cells from a mouse 7 d after
primary infection with 
 
L
 
.
 
 monocytogenes
 
 were added per well con-
taining 10
 
4
 
 
 
51
 
Cr-labeled P815. This procedure allowed testing of
primary, LLO
 
91–99
 
–specific effector T cells at five to six different
peptide concentrations, with maximum percentage of specific ly-
sis 
 
.
 
30% after 7 h of incubation. To compensate for the 
 
z
 
10-
fold higher frequency of LLO
 
91–99
 
–specific T cells at the peak of a
recall response, 10-fold fewer (6 
 
3 
 
10
 
5
 
) CD8
 
1
 
-enriched, recall
T cells were added per CTL assay well.
 
Staining and Analysis of CD8
 
1
 
 T Cells
 
Conventional Procedure.
 
Phenotypic characterization of LLO
 
91–99
 
–
specific T cells using PE-conjugated, tetrameric MHC/peptide
complexes together with staining for other surface molecules us-
ing directly conjugated mAbs was performed as described previ-
ously (20, 26). In brief, after blocking with unconjugated strepta-
vidin (0.5 mg/ml; Molecular Probes) and Fc-block (PharMingen),
 
z
 
5 
 
3 
 
10
 
5
 
 cells were incubated in FACS staining buffer (SB; PBS,
pH 7.45, 0.5% BSA, and 0.02% sodium azide) for 1 h on ice in
the presence of saturating concentrations of H2-K
 
d
 
/LLO
 
91–99
 
 tet-
ramers (0.25–0.5 mg/ml) and other mAbs. Subsequently, cells
were washed three times in SB and then fixed in 1% paraformal-
dehyde/PBS (pH 7.45). Flow cytometry was performed using a
FACScalibur
 
®
 
 and data were further analyzed with CELLQuest
software (Becton Dickinson). The following mAbs were used
(all obtained from PharMingen): Cy-Chrome–conjugated anti-
CD8
 
a
 
 (clone 53-6.7), FITC-conjugated anti-CD8
 
b
 
 (clone 53-
5.8), FITC-conjugated anti–TCR-
 
a
 
/
 
b
 
 (clone H57-597), FITC-
conjugated anti-TCR V
 
b
 
 segments (TCR V
 
b
 
2, 3, 4, 5.1/2, 6, 7,
8.1/2, 8.1-3(pan), 9, 10, 11, 12, 13, and 14), and FITC-conju-
gated anti-CD62L (clone MEL-14).
 
Tetramer-binding Assays.
 
Approximately 5 
 
3 
 
10
 
5
 
 T cells from
in vitro cultured T cell lines or CD8-enriched splenocytes were
blocked with unconjugated streptavidin and Fc block as described
above, and were subsequently incubated in SB for 0.5 h on ice in
the presence of a range of subsaturating concentrations of H2-K
 
d
 
/
LLO
 
91–99
 
 tetramers and saturating concentrations of Cy-Chrome–
conjugated anti-CD8
 
a
 
 mAb. The tetramer concentrations tested
ranged from 0.4 mg/ml (1:10 dilution of stock solution) to 25
 
m
 
g/ml (1:160). After incubation, cells were washed three times in
SB, fixed in 1% paraformaldehyde, and analyzed by flow cytome-
try as described above. 
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Tetramer Dissociation Assays.
 
Approximately 2 
 
3 
 
10
 
6
 
 T cells
from T cell lines or CD8-enriched splenocytes were blocked
with unconjugated streptavidin and Fc block as described above,
and subsequently incubated in SB for 1 h on ice in the presence
of saturating concentrations of H2-K
 
d
 
/LLO
 
91–99
 
 tetramers (0.5
mg/ml) and Cy-Chrome-conjugated anti-CD8
 
a
 
 mAb. After in-
cubation, cells were washed three times in SB, and subsequently
resuspended in 1 ml SB and transferred to a 15
 
8
 
C waterbath. At
the time points 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, and 7 h of incuba-
tion at 15
 
8
 
C, 100 
 
m
 
l samples were taken and directly transferred
to a FACS
 
®
 
 tube containing 100 
 
m
 
l 2% paraformaldehyde/PBS
(pH 7.45). Flow cytometry was performed as described above. 
 
Results
 
Repertoire Focusing of LLO
 
91–99
 
–specific T Cell Populations
Occurs during In Vivo T Cell Expansion.
 
In previous stud-
ies we have shown that T cell populations specific for the
immunodominant 
 
Listeria
 
 epitope LLO
 
91–99
 
 are character-
ized by highly diverse TCR V
 
b
 
 repertoires at the peak of
the primary response to infection, and that this broad TCR
repertoire is maintained by memory T cells. However, after
reinfection the TCR repertoire of LLO
 
91–99
 
–specific recall
T cells becomes more restricted (20). We infected BALB/c
mice with 
 
L
 
. monocytogenes and stained CD81 T cells with
H2-Kd/LLO91–99 tetramers and a panel of TCR Vb-spe-
cific mAbs during the peak primary response, the peak re-
call response, and 35 d after the peak recall response, which
represents a secondary memory T cell population (Fig. 1).
The repertoire of T cells entering the secondary memory
pool is nearly indistinguishable from the repertoire estab-
lished during the peak recall expansion (Fig. 1 A). As a
measure of TCR diversity, we calculated the ratio of TCR
Vb staining T cells of intermediate (2.5–10%) to high
(.10%) frequency for primary, recall, and secondary mem-
ory LLO91–99–specific T cell populations (Fig. 1 B). This
analysis demonstrates the loss of TCR diversity after T cell
expansion in response to recall infection, and suggests that
in vivo T cell expansion is a selective process, favoring the
replication of a subset of T cells within a diverse popula-
tion.
Is Selective In Vivo Expansion of T Cell Populations Attribut-
able to Enhanced Affinity for Antigen? Cytotoxic T cells
with higher affinity for a specific MHC/peptide ligand lyse
cells in the presence of lower targeting peptide concentra-
tions than CTL with lower affinity (28). If selective in vivo
expansion of LLO91–99–specific T cells relates to their affin-
ity, primary and recall CTL should differ in their peptide-
sensitivity in cytotoxicity assays. Therefore, we expanded
epitope-specific T cells after primary or recall infection and
tested them in CTL assays with titrations of the targeting
peptide. As shown in Fig. 2 A, T cells derived from the re-
call response had greater peptide sensitivity than T cells ex-
panded from the primary response. These differences are
not attributable to differences in TCR expression levels,
since TCR-a/b staining on the two CTL lines was equiv-
alent (Fig. 2 B). These data suggest that recall CTLs have
greater affinity for LLO91–99. Because in vitro T cell stimu-
lation might select for nonrepresentative T cell subpopula-
tions, direct ex vivo CTL assays were performed with sple-
nocytes isolated from mice after primary and recall
infection. As shown in Fig. 2 C, direct ex vivo CTL assays
also demonstrate the higher peptide sensitivity of recall
CTLs compared with primary CTLs. We typically find that
ex vivo stained CTLs at the peak of the recall response ex-
press slightly lower levels of surface TCR (Fig. 2 D) and
CD8a (26) than LLO91–99–specific CTLs at the peak of the
primary response. Although it might be anticipated that
lower TCR expression would decrease peptide sensitivities
in CTL assays, any such effect appears to be camouflaged
by the overall enhanced peptide sensitivity of recall CTLs.
Binding of Tetrameric H2-Kd/LLO91–99 Complexes Corre-
lates with Relative Affinity. The two major differences be-
tween primary and recall LLO91–99–specific T cell popula-
tions are the more focused TCR Vb repertoire and the
Figure 1. TCR repertoire focusing occurs during T cell expansion. Primary T cells were obtained from the peripheral blood of BALB/c mice 7 d after
sublethal infection and stained with LLO91–99 tetramers and a panel of TCR Vb-specific antibodies (white bars) as described in Materials and Methods. 35 d
after primary infection, the same mice were reinfected with a 50-fold higher dose of L. monocytogenes; peripheral blood lymphocytes were isolated and the
TCR Vb repertoire of LLO91–99–specific T cells was determined 5 d after reinfection (black bars). 35 d after reinfection, CD81 splenocytes from the same
mice were isolated and stained with LLO91–99 tetramers and the panel of TCR Vb-specific antibodies (hatched bars). (A) Representative TCR Vb pro-
file of an individual mouse during primary and recall infection with L. monocytogenes. (B) The “degree of diversity” decreases from primary to recall
LLO91–99–specific T cells, whereas no further changes occur during the transition from recall effector to secondary memory T cells. The degree of diver-
sity was estimated by the ratio of the number of TCR Vb segments detected in the range of 2.5–10% within an epitope-specific T cell population (gray
area in A) divided by the number of TCR Vb segments detected at .10%. Results from three different mice and standard deviations are shown.704 T Cell Affinity Maturation by Selective Expansion
greater peptide sensitivity of recall T cells. A recent study
showed that the binding kinetics of tetrameric MHC/pep-
tide complexes to T cell hybridomas directly reflect the af-
finity of TCR binding to MHC/peptide complexes, as de-
termined by BiaCore measurements (27). We therefore
tested LLO91–99–specific T cell lines with different peptide-
sensitivities for tetramer binding in the presence of a range
of tetramer concentrations. As shown in Fig. 3 (using the
same T cell lines as in Fig. 2, A and B), T cell lines with
higher peptide-sensitivity stain more intensely with subsat-
urating concentrations of LLO91–99 tetramers than T cell
lines with lower peptide sensitivity. The primary T cell line
stains with a broader range of intensities than the recall T
cell line, suggesting that the affinity of recall T cells is more
uniform and, on average, higher than the affinity of pri-
mary T cells.
Direct Ex Vivo Tetramer-binding Assays Indicate Higher Af-
finity of Recall T Cell Populations. To estimate the in vivo
affinities of T cell populations during primary and recall in-
fection, tetramer-binding assays were also performed with
directly isolated T cells. The proportion of activated
(CD62low) T cells staining with H2-Kd/LLO91–99 tetramers
decreases as the tetramers are diluted (Fig. 4). A difference
in tetramer staining between primary and recall T cells be-
comes apparent over the range of these titrations; the per-
centage of T cells that remain tetramer-positive is higher
for recall T cells than for primary T cells (Fig. 4 A). In ad-
dition to these quantitative changes, the staining intensity
of antigen-specific cells over the range of tetramer concen-
trations (Fig. 4 B) reveals that recall T cells bind higher lev-
els of tetramers at intermediate concentrations (1:20–1:80)
than primary LLO91–99–specific T cells. At lower tetramer
concentrations (1:160) the differences in staining intensities
between primary and recall LLO91–99–specific T cells are
lost.
The proportion of cells staining with tetramers and the
difference in the intensity of tetramer staining are not at-
tributable to differences in TCR or CD8 surface expres-
sion. First, TCR and CD8 expression levels on CTL lines
derived from primary and recall infection express identical
levels of TCR-a/b and CD8a while differing with respect
to tetramer staining at subsaturating concentrations (Fig. 3).
Second, with respect to directly isolated antigen-specific
T cells, both CD8 and TCR-a/b are more highly ex-
pressed during peak primary responses than during peak re-
call responses (Fig. 2 D and Fig. 5). Because CD8a/b het-
erodimers can affect the affinity of TCR interactions with
MHC/peptide complexes (29, 30), we determined expres-
sion levels of CD8a and CD8b on directly ex vivo isolated
primary and recall T cells. Staining of LLO91–99–specific
T cells revealed that they all express the CD8a/b het-
erodimer (Fig. 5, A and B). Co-staining with anti-CD8a
mAb 53-6.7 does not interfere with tetramer staining (31),
whereas anti-CD8b mAb 53-5.8, which can block CD8/
H2-Kd interaction (29), diminishes tetramer-staining inten-
Figure 2. Recall LLO91–99–specific T cells are characterized by higher
peptide sensitivity than primary effector CTLs. Short-term T cell lines (A
and B) and ex vivo T cells (C and D) were assayed in CTL assays (A and
C) or stained for TCR expression (B and D) as described in Materials and
Methods. (A) T cell lines were generated by short term in vitro peptide
stimulation for 5 d from primary day 7 (h) or reinfected day 5 (s) mice,
as described in Materials and Methods, and the percentage of specific lysis
in the presence of different concentrations of LLO91–99 peptide was deter-
mined by standard 51Cr-release assays using P815 (H2d) target cells. (B)
TCR-a/b surface expression of the two T cell lines shown in A. (C) Cr-
release assays as in A but with cells isolated directly ex vivo from primary
and recall infected mice and enriched for CD81 T cells. Four mice per
group, lines show mean values, symbols show data of individual mice. (D)
TCR-a/b surface expression of LLO91–99–specific, primary, or recall T
cells isolated directly ex vivo.
Figure 3. High affinity T cell lines bind higher levels of H2-Kd/LLO91–99
tetramers than do low affinity T cells. Short-term T cell lines (see Fig. 2,
A and B) were tested for their tetramer-binding capacity by incubating in
the presence of different, subsaturating concentrations of H2-Kd/LLO91–99
tetramers for 0.5 h on ice. (A) T cell line from the peak of the primary re-
sponse to L. monocytogenes; (B) T cell line from the peak of the recall re-
sponse.705 Busch and Pamer
sity of a subpopulation of LLO91–99–specific T cells (data
not shown). The percentage of tetramer positive cells
whose staining is diminished by anti-CD8b ranges from 10
to 40%, with substantial mouse to mouse variability after
both primary and recall infection. Importantly, the degree
of CD8 coreceptor dependence among primary and recall
T cells is overlapping, ruling out a role for CD8 in deter-
mining the differences in tetramer staining. Taken to-
gether, these data strongly suggest that TCR affinity for
H2-Kd/LLO91–99 complexes evolves and increases as T cells
expand during recall responses.
Tetrameric H2-Kd/LLO91–99 Complexes Dissociate from
High and Low Affinity T Cell Lines with Different Kinetics.
Because the affinity of TCR for MHC/peptide ligands is
determined by both on and off rates, we decided to deter-
mine whether the dissociation of tetramers from T cell
populations could be measured. Maintaining tetramer-
stained cells on ice resulted in essentially no loss of staining
over 7 h (Fig. 6, A and B). We next determined the
amount of tetramer dissociation at 158C. This temperature
was chosen in order to avoid the possibility that MHC class
I tetramers might induce TCR internalization, which
could confound the interpretation of the results. There is a
decrease over time in the staining intensity of tetramer-pos-
itive T cells upon incubation at 158C (Fig. 6, C and D).
Staining for TCR after the different incubation intervals
did not indicate any changes in TCR surface expression
levels, arguing against tetramer-induced TCR internaliza-
tion. Therefore, the decreased staining intensity is most
likely explained by dissociation of tetramers. Tetramer dis-
sociation occurs rapidly during the first hour of incubation
at 158C, perhaps resulting from the dissociation of partially
bound complexes. The rapid dissociation phase is followed
by a longer phase of slower dissociation.
To test if tetramer dissociation rates correlate with the
relative affinity of epitope-specific T cells, we tested high
and low affinity T cell lines (the same as used in Figs. 2 and
3) for tetramer dissociation (Fig. 7). Tetramers dissociate
more slowly from the cell surface of lines with high peptide
sensitivity (Fig. 2) and tetramer-binding capacity (Fig. 3)
than from low affinity T cell lines. These data indicate that
tetramer dissociation rates can be used to contrast the rela-
tive affinities of different, antigen-specific T cell popula-
tions for their cognate antigen.
Direct Ex Vivo Tetramer Dissociation Assays Confirm Affin-
ity Maturation during Selective Expansion. To more directly
demonstrate affinity maturation of complex, epitope-spe-
Figure 4. Direct ex vivo tet-
ramer-binding assays. CD8-enriched
splenocytes from BALB/c mice at
the peak of the primary and recall
response to L. monocytogenes were
tested in tetramer-binding assays. (A)
Dot plots of ex vivo binding for
CD81 primary and recall T cells,
showing H2-Kd/LLO91–99 tetramer
staining on the y axis and anti-
CD62L staining on the x axis. The
percentages of tetramer-positive cells
with an activated phenotype
(CD62Llow) are indicated for the dif-
ferent tetramer concentrations (one
representative mouse per group). (B)
Changes in the staining intensity of
tetramer-positive, CD62Llow T cells
(gate R1 in A) at different subsatu-
rating tetramer concentrations in di-
rect ex vivo binding assays. Four
mice were used per group; the lines
represent the mean values for each
group, and symbols show intensity
of tetramer positive T cells from in-
dividual mice. h, peak primary re-
sponse; s, peak recall response.
Figure 5. CD8a/b surface expression of LLO91–99–specific T cell pop-
ulations. CD8-enriched splenocytes from BALB/c mice at the peak of the
primary and recall response to L. monocytogenes were stained for CD8a
and CD8b surface expression within the LLO91–99 tetramer–positive T
cell population. Cells were first incubated in the presence of anti-CD8
antibodies, followed by staining with NeutrAvidin–PE-conjugated tet-
ramers. Histogram profiles of LLO91–99 tetramer-positive T cells for sur-
face expression of (A) CD8a (Fl-3: CyChr) and (B) CD8b (FL-1: FITC)
are shown.706 T Cell Affinity Maturation by Selective Expansion
cific T cell populations, tetramer dissociation assays were
performed on freshly isolated antigen-specific T cells. Spleno-
cytes at the peak of a primary or recall response to L. mono-
cytogenes were enriched for CD81 T cells and stained with
saturating concentrations of tetramers. After washing off
unbound tetramers, the temperature was switched to 158C
and tetramer dissociation rates were determined by flow
cytometry after increasing time intervals. As shown in Fig.
8 A, more than 50% of H2-Kd/LLO91–99 tetramer-positive,
primary T cells with an activated phenotype (CD62Llow)
disappear from the R1 quadrant within the first 0.5 h, and
only 25% of tetramer-positive T cells remain after 3 h. In
contrast, LLO91–99–specific recall T cells are characterized
by much lower tetramer dissociation rates; there is minimal
loss of surface-bound tetramers during the first 0.5 h, and
even at the end of the assay (7 h), .50% of the population
remains tetramer positive. This difference between the pri-
mary and recall T cell populations is highly reproducible,
without any demonstrable overlap in dissociation rates be-
tween primary and recall T cells isolated from three mice in
each group (Fig. 8 B).
Discussion
Our studies of the evolution of a complex, antigen-spe-
cific T cell population responding to bacterial infection
show the following: (a) TCR repertoire focusing occurs
during T cell expansion; (b) peptide sensitivity, as measured
by direct ex vivo CTL assays, is greater for recall than for
primary antigen-specific T cell populations; and (c) the af-
finity of T cells for antigen, as measured by tetramer associ-
ation and dissociation rates, increases as memory T cells ex-
pand into a recall effector T cell population. These findings
are novel, demonstrating for the first time that T cells with
higher affinities for their antigen have a selective advantage
during in vivo expansion.
Because of the difficulty identifying and characterizing
antigen-specific T cell populations, very little is known
about their in vivo kinetics and dynamics in response to an-
tigen. Most studies of in vivo T cell responses have focused
on experimental systems where T cell populations with
very narrow TCR repertoires respond to an immunodom-
inant epitope (18, 32–34). Other studies have used the
adoptive transfer of T cells from TCR transgenic mice into
antigen-immunized recipient mice to investigate the in
vivo activation and expansion of clonal T cell populations
(35, 36). However, most primary T cell responses to patho-
gens are highly complex and characterized by very diverse
TCR repertoires. This complexity might enable antigen-
specific T cell populations to undergo changes during in
vivo T cell responses. Until recently, complex, antigen-
specific T cell populations could be studied only indirectly
(19, 24). With the introduction of tetramerized MHC/pep-
tide molecules as epitope-specific T cell staining reagents
(37), it is now possible to study highly complex, epitope-
specific T cell populations directly ex vivo (26, 31, 38).
In this report we show that TCR repertoire focusing of
LLO91–99–specific T cells after reinfection with L. monocytog-
Figure 6. Tetramers dissociate from the cell surface of stained cells. An
LLO91–99–specific T cell line was stained on ice with saturating concentra-
tions of H2-Kd/LLO91–99 tetramers, and unbound reagent was washed off.
Stained cells were either incubated for 7 h either on ice or at 158C. Sam-
ples were taken at increasing time intervals, fixed, and analyzed for the in-
tensity of tetramer staining. Histograms demonstrate tetramer dissociation
(decreased staining intensity) on ice (A) and at 158C (C). The kinetics of
tetramer dissociation and TCR-a/b surface expression on ice (B) or at
158C (D) are plotted. Tetramer staining is expressed as percentage of
maximal staining intensity (time point 0 5 100%); TCR-a/b surface ex-
pression was determined by staining of samples on ice after the indicated
incubation in the dissociation rate assay and is also expressed as percentage
of maximal staining intensity (time point 0 5 100%).
Figure 7. Tetramer dissociation rates of high and low affinity T cell
lines. Primary and recall-derived, LLO91–99–specific T cell lines (see Figs.
2 and 3) were tested for tetramer dissociation at 158C, as described in Fig.
5. h, T cell line from the peak primary response to L. monocytogenes; s,
T cell line from the peak recall response.707 Busch and Pamer
enes results from the selective expansion of high affinity
T cells within the epitope-specific population. These find-
ings agree with other studies demonstrating the evolution of
antigen-specific T cell populations for CD81 virus-specific
T cell responses (19) and antigen-specific CD41 T helper cell
responses (18). The assays to measure relative TCR–ligand
affinities by determining association and dissociation rates
of tetrameric MHC/peptide complexes described in this
paper should be readily applicable to studies of other model
systems. It will be interesting to determine whether affinity
maturation is a general feature of in vivo expansion of di-
verse T cell populations or if there are differences among
populations with different antigen specificities. In experi-
mental systems where primary antigen-specific T cell pop-
ulations are characterized by a restricted TCR repertoire,
no changes in the composition of these populations after
repeated antigen exposures were found (32, 39). However,
it is possible that the limited repertoire of these T cell pop-
ulations does not provide a sufficient degree of complexity
to measure maturation.
What are the mechanisms driving selective expansion of
high affinity T cells during the in vivo T cell response to
L. monocytogenes infection? It is possible that higher TCR af-
finity for antigen increases the likelihood that a T cell will
become activated and expand upon exposure to antigen. In
this setting, antigen concentration and the kinetics of
epitope presentation would regulate the extent of affinity
maturation; high affinity T cells that recognize low antigen
concentrations would be activated earlier and/or for a
longer period of time than low affinity T cells. Lower anti-
gen concentrations after reinfection with L. monocytogenes
might explain the selective expansion of high affinity
T cells during the recall response. However, preliminary
experiments analyzing recall responses to different doses of
L. monocytogenes demonstrate similar extents of in vivo T
cell expansion and TCR repertoire focusing (data not
shown), arguing against this hypothesis. Alternatively, T
cells within an epitope-specific population may all interact
with antigen, but low affinity T cells may receive a qualita-
tively different signal than high affinity T cells. Studies with
altered peptide ligands have shown that differences in the
affinity of TCR–ligand engagement can activate different
signaling pathways, leading to different effector functions
and rates of T cell proliferation (40). The thresholds and re-
quirements for activation of these different signaling path-
ways are distinct and dependent on the kinetics and affinity
of TCR–ligand interactions (41). Qualitatively different
signals might turn on different programs for T cell prolifer-
ation, with high affinity T cells undergoing more or faster
cell divisions than low affinity T cells. It is also possible that
qualitatively different signals after TCR–ligand interactions
lead to phenotypic differences among activated T cells,
such as the surface expression of IL-2 or IL-15 receptors,
which influence T cell susceptibility to proliferative and
antiapoptotic signals from the inflammatory environment.
What are the functional implications of in vivo T cell af-
finity maturation for pathogen-specific immunity? It is
likely that high affinity T cells respond earlier and faster to
infection than low affinity T cells specific for the same anti-
gen. Thus, selectively expanding the high affinity subset of
Figure 8. Direct ex vivo tetramer
dissociation rates confirm affinity
maturation. Tetramer dissociation
assays were performed on CD8-
enriched splenocytes isolated from
BALB/c mice at the peak of the pri-
mary or recall response to L. monocy-
togenes infection. (A) Dot plots of the
ex vivo dissociation assays for CD81
primary and recall T cells, showing
H2-Kd/LLO91–99 tetramer staining
on the y axis and anti-CD62L stain-
ing on the x axis. Percentages of tet-
ramer-positive cells with an acti-
vated phenotype (CD62Llow) for the
different time points are indicated
(one representative mouse per
group). (B) The decline in tetramer
staining at 158C of T cells isolated
from primary (h) or recall (s) mice
is plotted as the percentage of cells
that remain in quadrant R1 after the
increasing incubation intervals (T0 is
assigned a value of 100%). Three
mice were tested for each group; the
symbols represent the values ob-
tained for CD81 T cells isolated
from individual mice, with lines in-
dicating the mean of three mice dur-
ing primary and recall infection.708 T Cell Affinity Maturation by Selective Expansion
antigen-specific T cells, and consequently increasing their
precursor frequency within the memory T cell pool, could
increase the quality of immunity. Indeed, adoptive transfer
of HIV-specific CD81 T cells with different affinity for an-
tigen demonstrated that high affinity T cells are 100–1,000-
fold more efficient in virus clearance than are low affinity
T cells (42). Determining the cellular and molecular basis
for the qualitative evolution of epitope-specific T cell pop-
ulations after in vivo antigen challenge may provide new
strategies for vaccination and immunotherapy.
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